Literature DB >> 3680088

The antibiotic sensitivity of the Bacteroides fragilis group in the United Kingdom.

A R Fox1, I Phillips.   

Abstract

Eight hundred and sixty-two cultures of penicillin-resistant anaerobic Gram-negative bacilli collected from 14 centres in the United Kingdom were identified. Six hundred and fifty-one were members of the Bacteroides fragilis group, and their sensitivity to 14 antibiotics was determined by a microtitre method. Among the beta-lactams, moderate resistance to ampicillin (MIC greater than or equal to 8 mg/l) was common, (B. ovatus 100%, B. thetaiotaomicron 95%, B. fragilis 76%, B. distasonis 50%, B. vulgatus 25%) but high-level resistance (MIC greater than 128 mg/l) was uncommon (B. fragilis 4%, B. ovatus 4%, B. vulgatus 3%). In B. fragilis, moderate resistance to other beta-lactams was less common (cefoxitin 16%, mezlocillin 13% and cefotetan 7%), though in most non-B. fragilis species, higher numbers were moderately resistant. High level resistance to these three beta-lactams was rare. Resistance to penems (MIC greater than 4 mg/l) was not detected. All isolates of B. fragilis tested were sensitive to 16 mg/l of ciprofloxacin and ofloxacin, and 68% and 81% of isolates were sensitive to less than 4 mg/l, but one isolate of B. uniformis and one of B. thetaiotaomicron proved highly resistant. Clindamycin resistance was uncommon (1% of B. fragilis and 10% other B. fragilis group isolates were resistant to 2 mg/l clindamycin) with isolates resistant to clindamycin often also resistant to erythromycin. Tetracycline resistance was common in all species and occurred in 40% of isolates. Resistance to chloramphenicol, metronidazole or rifampicin was not detected. Significant differences were observed between the sensitivity of B. fragilis and other members of the B. fragilis group to mezlocillin, cefotetan, cefoxitin and the quinolones. There was no clear trend towards higher resistance in any one area of the country.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3680088     DOI: 10.1093/jac/20.4.477

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  13 in total

1.  Antibiotic sensitivity of the Bacteroides fragilis group in Europe. European Study Group.

Authors:  I Phillips; A King; C E Nord; B Hoffstedt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

Review 2.  Susceptibility testing of anaerobic bacteria: myth, magic, or method?

Authors:  H M Wexler
Journal:  Clin Microbiol Rev       Date:  1991-10       Impact factor: 26.132

Review 3.  Review of methods for susceptibility testing of anaerobes.

Authors:  R J Zabransky
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-11       Impact factor: 3.267

4.  Survey of the susceptibility patterns of Bacteroides fragilis group strains in France from 1977 to 1992.

Authors:  L Dubreuil; J Breuil; A Dublanchet; A Sedallian
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-11       Impact factor: 3.267

5.  Susceptibility of Bacteroides non-fragilis and fusobacteria to amoxicillin, amoxicillin/clavulanate, ticarcillin, ticarcillin/clavulanate, cefoxitin, imipenem and metronidazole.

Authors:  M R Jacobs; S K Spangler; P C Appelbaum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-06       Impact factor: 3.267

6.  In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria.

Authors:  H M Wexler; E Molitoris; D Molitoris; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

7.  Susceptibility patterns and characterization of beta-lactamases in clinical isolates of Bacteroides fragilis.

Authors:  P Mastrantonio; P Spigaglia; A Sebastianelli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-06       Impact factor: 3.267

Review 8.  Evolution in antibiotic susceptibility of Bacteroides fragilis group strains in France based on periodic surveys.

Authors:  L Dubreuil; M Derriennic; A Sedallian; C Romond; A L Courtieu
Journal:  Infection       Date:  1989 May-Jun       Impact factor: 3.553

9.  Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989.

Authors:  C Betriu; C Cabronero; M Gomez; J J Picazo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

10.  Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group.

Authors:  E J Goldstein; D M Citron
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.